{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:30:58Z","timestamp":1760401858568,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073947"],"award-info":[{"award-number":["82073947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04326-8","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:30:09Z","timestamp":1760085009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and tissue-level validation of ferroptosis-related genes in small intestinal neuroendocrine neoplasms based on machine learning"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuang","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"1","key":"4326_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00535-6","volume":"11","author":"XB Zhang","year":"2024","unstructured":"Zhang XB, Fan YB, Jing R, et al. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Mil Med Res. 2024;11(1):35. https:\/\/doi.org\/10.1186\/s40779-024-00535-6.","journal-title":"Mil Med Res"},{"issue":"10","key":"4326_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united States. JAMA Oncol. 2017;3(10):1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol"},{"issue":"3","key":"4326_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli S, Bartsch DK, Capdevila J, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255\u201365. https:\/\/doi.org\/10.1159\/000464292.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"4326_CR4","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EJE-14-0354","volume":"172","author":"T Alonso-Gordoa","year":"2015","unstructured":"Alonso-Gordoa T, Capdevila J, Grande E. GEP-NETs update: biotherapy for neuroendocrine tumours. Eur J Endocrinol. 2015;172(1):R31\u201346. https:\/\/doi.org\/10.1530\/EJE-14-0354.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"4326_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14737140.2016.1207534","volume":"16","author":"S Pusceddu","year":"2016","unstructured":"Pusceddu S, Femia D, Lo Russo G, et al. Update on medical treatment of small intestinal neuroendocrine tumors. Expert Rev Anticancer Ther. 2016;16(9):969\u201376. https:\/\/doi.org\/10.1080\/14737140.2016.1207534.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4326_CR6","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.2147\/CMAR.S372776","volume":"14","author":"G Arrivi","year":"2022","unstructured":"Arrivi G, Verrico M, Roberto M, et al. Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis. Cancer Manag Res. 2022;14:3507\u201323. https:\/\/doi.org\/10.2147\/CMAR.S372776.","journal-title":"Cancer Manag Res"},{"issue":"10022","key":"4326_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","volume":"387","author":"JC Yao","year":"2016","unstructured":"Yao JC, Fazio N, Singh S, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or Gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet. 2016;387(10022):968\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(15)00817-X.","journal-title":"Lancet"},{"issue":"3","key":"4326_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371(3):224\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1316158.","journal-title":"N Engl J Med"},{"issue":"4","key":"4326_CR9","doi-asserted-by":"publisher","first-page":"e230203","DOI":"10.1530\/ERC-23-0203","volume":"31","author":"IS Cordero-Hernandez","year":"2024","unstructured":"Cordero-Hernandez IS, Ross AC, Dasari A, Halperin DM, Chasen B, Yao JC. Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024;31(4):e230203. https:\/\/doi.org\/10.1530\/ERC-23-0203.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"4326_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4326_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","volume":"128","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Tang D, Kroemer G, Ren J. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. Br J Cancer. 2023;128(2):190\u2013205. https:\/\/doi.org\/10.1038\/s41416-022-01998-x.","journal-title":"Br J Cancer"},{"issue":"7","key":"4326_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2024.07.038","volume":"167","author":"X Cheng","year":"2024","unstructured":"Cheng X, Dai E, Wu J, et al. Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response. Gastroenterology. 2024;167(7):1345\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2024.07.038.","journal-title":"Gastroenterology"},{"issue":"7\u20139","key":"4326_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/ars.2023.0246","volume":"39","author":"W Huang","year":"2023","unstructured":"Huang W, Aabed N, Shah YM. Reactive oxygen species and ferroptosis at the nexus of inflammation and colon cancer. Antioxid Redox Signal. 2023;39(7\u20139):551\u201368. https:\/\/doi.org\/10.1089\/ars.2023.0246.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"4326_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4326_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8(1):372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4326_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4326_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011.","journal-title":"Cancer Cell"},{"issue":"1","key":"4326_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):315. https:\/\/doi.org\/10.1186\/s13046-024-03235-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"4326_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-023-01987-8","volume":"58","author":"M Murakami","year":"2023","unstructured":"Murakami M, Fujimori N, Nakata K, et al. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1\/G2. J Gastroenterol. 2023;58(6):586\u201397. https:\/\/doi.org\/10.1007\/s00535-023-01987-8.","journal-title":"J Gastroenterol"},{"issue":"1","key":"4326_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.diii.2024.08.003","volume":"106","author":"F Lopez-Ramirez","year":"2025","unstructured":"Lopez-Ramirez F, Soleimani S, Azadi JR, et al. Radiomics machine learning algorithm facilitates detection of small pancreatic neuroendocrine tumors on CT. Diagn Interv Imaging. 2025;106(1):28\u201340. https:\/\/doi.org\/10.1016\/j.diii.2024.08.003.","journal-title":"Diagn Interv Imaging"},{"issue":"Pt 3","key":"4326_CR21","doi-asserted-by":"publisher","first-page":"137117","DOI":"10.1016\/j.ijbiomac.2024.137117","volume":"282","author":"Z Jia","year":"2024","unstructured":"Jia Z, Zhang J, Li Z, Ai L. Identification of ferroptosis-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approaches. Int J Biol Macromol. 2024;282(Pt 3):137117. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137117.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"4326_CR22","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.21037\/tp-24-323","volume":"13","author":"J Cheng","year":"2024","unstructured":"Cheng J, Dong X, Yang Y, Qin X, Zhou X, Zhang D. Synergistic machine learning models utilizing ferroptosis-related genes for improved neuroblastoma outcome prediction. Transl Pediatr. 2024;13(12):2164\u201382. https:\/\/doi.org\/10.21037\/tp-24-323.","journal-title":"Transl Pediatr"},{"key":"4326_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1362278","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, Zhang Z, Tang J, et al. Ferroptosis-related biomarkers for adamantinomatous craniopharyngioma treatment: conclusions from machine learning techniques. Front Endocrinol (Lausanne). 2024;15:1362278. https:\/\/doi.org\/10.3389\/fendo.2024.1362278.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4326_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1099272","volume":"14","author":"H Huang","year":"2023","unstructured":"Huang H, Ye Z, Li Z, et al. Employing machine learning using ferroptosis-related genes to construct a prognosis model for patients with osteosarcoma. Front Genet. 2023;14:1099272. https:\/\/doi.org\/10.3389\/fgene.2023.1099272.","journal-title":"Front Genet"},{"issue":"11","key":"4326_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3724\/abbs.2022162","volume":"54","author":"Z Ye","year":"2022","unstructured":"Ye Z, Chen H, Ji S, et al. MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors. Acta Biochim Biophys Sin. 2022;54(11):1599\u2013609. https:\/\/doi.org\/10.3724\/abbs.2022162.","journal-title":"Acta Biochim Biophys Sin"},{"key":"4326_CR26","doi-asserted-by":"publisher","first-page":"153332","DOI":"10.1016\/j.phymed.2020.153332","volume":"79","author":"G Yan","year":"2020","unstructured":"Yan G, Dawood M, B\u00f6ckers M, et al. Multiple modes of cell death in neuroendocrine tumors induced by artesunate. Phytomedicine. 2020;79:153332. https:\/\/doi.org\/10.1016\/j.phymed.2020.153332.","journal-title":"Phytomedicine"},{"key":"4326_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1110396","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Meng Y, Huang X, et al. Potential effective diagnostic biomarker in patients with primary and metastatic small intestinal neuroendocrine tumors. Front Genet. 2023;14:1110396. https:\/\/doi.org\/10.3389\/fgene.2023.1110396.","journal-title":"Front Genet"},{"issue":"3","key":"4326_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pharmthera.2006.03.008","volume":"112","author":"A Kalsotra","year":"2006","unstructured":"Kalsotra A, Strobel HW. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol Ther. 2006;112(3):589\u2013611. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.03.008.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4326_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41598-024-84998-6","volume":"15","author":"W Yin","year":"2025","unstructured":"Yin W, Ao Y, Jia Q, et al. Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer. Sci Rep. 2025;15(1):874. https:\/\/doi.org\/10.1038\/s41598-024-84998-6.","journal-title":"Sci Rep"},{"issue":"5","key":"4326_CR30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen MS, Ruiz J, Watts JL. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells. 2023;12(5):804. https:\/\/doi.org\/10.3390\/cells12050804.","journal-title":"Cells"},{"issue":"5","key":"4326_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-07-5983","volume":"68","author":"D Ray","year":"2008","unstructured":"Ray D, Kiyokawa H. Cdc25A phosphatase: a rate-limiting oncogene that determines genomic stability. Cancer Res. 2008;68(5):1251\u20133. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5983.","journal-title":"Cancer Res"},{"issue":"7","key":"4326_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jtho.2017.04.018","volume":"12","author":"MN Adams","year":"2017","unstructured":"Adams MN, Burgess JT, He Y, et al. Expression of CDCA3 is a prognostic biomarker and potential therapeutic target in non-small cell lung cancer. J Thorac Oncol. 2017;12(7):1071\u201384. https:\/\/doi.org\/10.1016\/j.jtho.2017.04.018.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4326_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1006\/excr.1998.3940","volume":"240","author":"D Dixon","year":"1998","unstructured":"Dixon D, Moyana T, King MJ. Elevated expression of the cdc25A protein phosphatase in colon cancer. Exp Cell Res. 1998;240(2):236\u201343. https:\/\/doi.org\/10.1006\/excr.1998.3940.","journal-title":"Exp Cell Res"},{"issue":"5","key":"4326_CR34","first-page":"1764","volume":"9","author":"X Xu","year":"2003","unstructured":"Xu X, Yamamoto H, Sakon M, et al. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res. 2003;9(5):1764\u201372.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4326_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10620-007-9964-4","volume":"53","author":"X Xing","year":"2008","unstructured":"Xing X, Chen J, Chen M. Expression of CDC25 phosphatases in human gastric cancer. Dig Dis Sci. 2008;53(4):949\u201353. https:\/\/doi.org\/10.1007\/s10620-007-9964-4.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"4326_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41419-021-04342-y","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Zeng J, Li LJ, Xue M, He SL. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells. Cell Death Dis. 2021;12(11):1055. https:\/\/doi.org\/10.1038\/s41419-021-04342-y.","journal-title":"Cell Death Dis"},{"key":"4326_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1131473","volume":"13","author":"D Lin","year":"2023","unstructured":"Lin D, Hu B, Zhu S, Wu Y. Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma. Front Oncol. 2023;13:1131473. https:\/\/doi.org\/10.3389\/fonc.2023.1131473.","journal-title":"Front Oncol"},{"issue":"2","key":"4326_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00309-y","volume":"10","author":"Y Cicir\u00f2","year":"2021","unstructured":"Cicir\u00f2 Y, Sala A. MYB oncoproteins: emerging players and potential therapeutic targets in human cancer. Oncogenesis. 2021;10(2):19. https:\/\/doi.org\/10.1038\/s41389-021-00309-y.","journal-title":"Oncogenesis"},{"issue":"12","key":"4326_CR39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","volume":"19","author":"S Hao","year":"2017","unstructured":"Hao S, Yu J, He W, et al. Cysteine dioxygenase 1 mediates Erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19(12):1022\u201332. https:\/\/doi.org\/10.1016\/j.neo.2017.10.005.","journal-title":"Neoplasia"},{"issue":"1","key":"4326_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61\u201372. https:\/\/doi.org\/10.1016\/S1470-2045(07)70410-2.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4326_CR41","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/ERC-17-0269","volume":"25","author":"V Marotta","year":"2018","unstructured":"Marotta V, Zatelli MC, Sciammarella C, et al. Chromogranin A as Circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocr Relat Cancer. 2018;25(1):R11\u201329. https:\/\/doi.org\/10.1530\/ERC-17-0269.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"4326_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00428-021-03211-5","volume":"480","author":"B Konukiewitz","year":"2022","unstructured":"Konukiewitz B, Jesinghaus M, Kasajima A, Kl\u00f6ppel G. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls. Virchows Arch. 2022;480(2):247\u201357. https:\/\/doi.org\/10.1007\/s00428-021-03211-5.","journal-title":"Virchows Arch"},{"key":"4326_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111726","volume":"555","author":"R Uhlig","year":"2022","unstructured":"Uhlig R, Dum D, Gorbokon N, et al. Synaptophysin and chromogranin A expression analysis in human tumors. Mol Cell Endocrinol. 2022;555:111726. https:\/\/doi.org\/10.1016\/j.mce.2022.111726.","journal-title":"Mol Cell Endocrinol"},{"issue":"14","key":"4326_CR44","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/cancers16142506","volume":"16","author":"J Gertner","year":"2024","unstructured":"Gertner J, Tsoli M, Hayes AR, et al. The clinical utility of the netest in patients with small intestinal neuroendocrine neoplasms (Si-NENs): A Real-Life study. Cancers (Basel). 2024;16(14):2506. https:\/\/doi.org\/10.3390\/cancers16142506.","journal-title":"Cancers (Basel)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04326-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:23:44Z","timestamp":1760358224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04326-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures related to human were conducted according to the criteria set by the declaration of Helsinki and the written informed consent was obtained from each donor under the supervision of the Ethics Committee of the First Affiliated Hospital of Anhui Medical University (LLSC20220610).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"720"}}